|
Volumn 88, Issue 3, 2001, Pages 202-208
|
p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder
|
Author keywords
Bladder neoplasms; Immunohistochemistry; p53; Protein; Radiation; Radiation effects; Radiobiology; Radiotherapy; Tolerance
|
Indexed keywords
PROTEIN MDM2;
PROTEIN P21;
PROTEIN P53;
TUMOR MARKER;
ADULT;
AGED;
ARTICLE;
BLADDER BIOPSY;
BLADDER CARCINOMA;
CANCER STAGING;
CANCER SURVIVAL;
CONTROLLED STUDY;
CYSTECTOMY;
FEMALE;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
MAJOR CLINICAL STUDY;
MALE;
MINIMAL RESIDUAL DISEASE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RADIATION DOSE;
RADIATION RESPONSE;
RADIOSENSITIVITY;
TRANSITIONAL CELL CARCINOMA;
ADULT;
AGED;
CARCINOMA, TRANSITIONAL CELL;
CYSTECTOMY;
FEMALE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
MALE;
MIDDLE AGED;
NUCLEAR PROTEINS;
ONCOGENE PROTEIN P21(RAS);
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-MDM2;
RETROSPECTIVE STUDIES;
TUMOR MARKERS, BIOLOGICAL;
TUMOR SUPPRESSOR PROTEIN P53;
URINARY BLADDER NEOPLASMS;
|
EID: 0034834191
PISSN: 14644096
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1464-410X.2001.02268.x Document Type: Article |
Times cited : (22)
|
References (44)
|